Skip to content

Bausch + Lomb BLCO Intangible assets — net

Intangible assets — net at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
AbbVie logo
AbbVieABBV
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
PBH
Prestige Consumer HealthcarePBH
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Organon logo
OrganonOGN

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.43B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's intangible assets — net?
Bausch + Lomb (BLCO) reported intangible assets — net of $1.43B in Q1 2026.
How has Bausch + Lomb's intangible assets — net changed year-over-year?
Bausch + Lomb's intangible assets — net decreased by 12.3% year-over-year, from $1.63B to $1.43B.
What is the long-term trend for Bausch + Lomb's intangible assets — net?
Over 4 years (2021 to 2025), Bausch + Lomb's intangible assets — net has grown at a 27.2% compound annual growth rate (CAGR), from $566M to $1.48B.